{"disease":{"id":"severe-hypoglycemia","name":"severe hypoglycemia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03655223","title":"Early Check: Expanded Screening in Newborns","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":30000,"lead_sponsor_name":"RTI International","has_results":false},{"nct_id":"NCT06770621","title":"Longitudinal Study of the GLUcagon REsponse to Hypoglycemia in Children and Adolescents With New-onset Type 1 DIAbetes","phase":"NA","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Cliniques universitaires Saint-Luc- Université Catholique de Louvain","has_results":false},{"nct_id":"NCT04863872","title":"Comparing the Effectiveness of Two Approaches to Preventing Severe Hypoglycemia in Patients With Type 2 Diabetes (PHT2)","phase":"NA","overall_status":"COMPLETED","enrollment_count":259,"lead_sponsor_name":"Kaiser Permanente","has_results":true},{"nct_id":"NCT03890432","title":"GLUCOSAFE 2 - A New Tool for Nutritional Management and Insulin-therapy in the Intensive Care Unit (ICU)","phase":"NA","overall_status":"COMPLETED","enrollment_count":213,"lead_sponsor_name":"HEIDEGGER CP","has_results":false},{"nct_id":"NCT03738865","title":"G-Pen Compared to Glucagen Hypokit for Severe Hypoglycemia Rescue in Adults With Type 1 Diabetes","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":132,"lead_sponsor_name":"Xeris Pharmaceuticals","has_results":true},{"nct_id":"NCT03439072","title":"G-Pen™ Compared to Lilly Glucagon for Hypoglycemia Rescue in Adults With Type 1 Diabetes","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":81,"lead_sponsor_name":"Xeris Pharmaceuticals","has_results":true},{"nct_id":"NCT04786262","title":"A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":52,"lead_sponsor_name":"Vertex Pharmaceuticals Incorporated","has_results":false},{"nct_id":"NCT07126873","title":"A Safety, Tolerability, and Efficacy Study of E-islet 01 in Participants With Type 1 Diabetes","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":21,"lead_sponsor_name":"EndoCell Therapeutics, Inc.","has_results":false},{"nct_id":"NCT06575426","title":"A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":13,"lead_sponsor_name":"Otsuka Pharmaceutical Factory, Inc.","has_results":false}],"total":9},"guidelines":[],"source":"Drug Landscape verified database"}